Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of Bavarian Nordic's PXVX-0317?
PXVX-0317 is a subunit vaccine commercialized by Bavarian Nordic, with a leading Pre-Registration program in Chikungunya Fever. According to Globaldata,...